Persistence Market Research Company
Customize Now Get FREE Sample

Oncolytic Virus Immunotherapy Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

Oncolytic Virus Immunotherapy Market by Virus Type (Adenovirus, Herpes Simplex Virus (HSV), Vaccinia Virus, Reovirus, Newcastle Disease Virus, Others), Route of Administration (Intratumoral, Intravenous, Others), Indication (Melanoma, Breast cancer, Lung cancer, Ovarian cancer, Prostate cancer, Others), End-user (Hospitals & oncology centers, Ambulatory surgical centers, Cancer research institutes, Others) , and Regional Analysis from 2025 - 2032

ID: PMRREP15262| 196 Pages | 29 Nov 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Oncolytic Virus Immunotherapy Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Disease Epidemiology
    4. Value Chain Analysis
    5. Key Deals and Mergers
    6. PESTLE Analysis
    7. Porter’s Five Force Analysis
  4. Global Oncolytic Virus Immunotherapy Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
    3. Global Oncolytic Virus Immunotherapy Market Outlook: Virus Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Virus Type, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025 - 2032
        1. Adenovirus
        2. Herpes Simplex Virus (HSV)
        3. Vaccinia Virus
        4. Reovirus
        5. Newcastle Disease Virus
        6. Others
      4. Market Attractiveness Analysis: Virus Type
    4. Global Oncolytic Virus Immunotherapy Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
        1. Intratumoral
        2. Intravenous
        3. Others
      4. Market Attractiveness Analysis: Route of Administration
    5. Global Oncolytic Virus Immunotherapy Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
        1. Melanoma
        2. Breast cancer
        3. Lung cancer
        4. Ovarian cancer
        5. Prostate cancer
        6. Others
      4. Market Attractiveness Analysis: Indication
    6. Global Oncolytic Virus Immunotherapy Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
        1. Hospitals & oncology centers
        2. Ambulatory surgical centers
        3. Cancer research institutes
        4. Others
      4. Market Attractiveness Analysis: End User
  5. Global Oncolytic Virus Immunotherapy Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Oncolytic Virus Immunotherapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Virus Type
      3. By Route of Administration
      4. By Indication
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025 - 2032
      1. Adenovirus
      2. Herpes Simplex Virus (HSV)
      3. Vaccinia Virus
      4. Reovirus
      5. Newcastle Disease Virus
      6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Intratumoral
      2. Intravenous
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Melanoma
      2. Breast cancer
      3. Lung cancer
      4. Ovarian cancer
      5. Prostate cancer
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Hospitals & oncology centers
      2. Ambulatory surgical centers
      3. Cancer research institutes
      4. Others
    8. Market Attractiveness Analysis
  7. Europe Oncolytic Virus Immunotherapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Virus Type
      3. By Route of Administration
      4. By Indication
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025 - 2032
      1. Adenovirus
      2. Herpes Simplex Virus (HSV)
      3. Vaccinia Virus
      4. Reovirus
      5. Newcastle Disease Virus
      6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Intratumoral
      2. Intravenous
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Melanoma
      2. Breast cancer
      3. Lung cancer
      4. Ovarian cancer
      5. Prostate cancer
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Hospitals & oncology centers
      2. Ambulatory surgical centers
      3. Cancer research institutes
      4. Others
    8. Market Attractiveness Analysis
  8. East Asia Oncolytic Virus Immunotherapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Virus Type
      3. By Route of Administration
      4. By Indication
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025 - 2032
      1. Adenovirus
      2. Herpes Simplex Virus (HSV)
      3. Vaccinia Virus
      4. Reovirus
      5. Newcastle Disease Virus
      6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Intratumoral
      2. Intravenous
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Melanoma
      2. Breast cancer
      3. Lung cancer
      4. Ovarian cancer
      5. Prostate cancer
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Hospitals & oncology centers
      2. Ambulatory surgical centers
      3. Cancer research institutes
      4. Others
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Oncolytic Virus Immunotherapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Virus Type
      3. By Route of Administration
      4. By Indication
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025 - 2032
      1. Adenovirus
      2. Herpes Simplex Virus (HSV)
      3. Vaccinia Virus
      4. Reovirus
      5. Newcastle Disease Virus
      6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Intratumoral
      2. Intravenous
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Melanoma
      2. Breast cancer
      3. Lung cancer
      4. Ovarian cancer
      5. Prostate cancer
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Hospitals & oncology centers
      2. Ambulatory surgical centers
      3. Cancer research institutes
      4. Others
    8. Market Attractiveness Analysis
  10. Latin America Oncolytic Virus Immunotherapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Virus Type
      3. By Route of Administration
      4. By Indication
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025 - 2032
      1. Adenovirus
      2. Herpes Simplex Virus (HSV)
      3. Vaccinia Virus
      4. Reovirus
      5. Newcastle Disease Virus
      6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Intratumoral
      2. Intravenous
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Melanoma
      2. Breast cancer
      3. Lung cancer
      4. Ovarian cancer
      5. Prostate cancer
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Hospitals & oncology centers
      2. Ambulatory surgical centers
      3. Cancer research institutes
      4. Others
    8. Market Attractiveness Analysis
  11. Middle East & Africa Oncolytic Virus Immunotherapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Virus Type
      3. By Route of Administration
      4. By Indication
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025 - 2032
      1. Adenovirus
      2. Herpes Simplex Virus (HSV)
      3. Vaccinia Virus
      4. Reovirus
      5. Newcastle Disease Virus
      6. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025 - 2032
      1. Intratumoral
      2. Intravenous
      3. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Melanoma
      2. Breast cancer
      3. Lung cancer
      4. Ovarian cancer
      5. Prostate cancer
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Hospitals & oncology centers
      2. Ambulatory surgical centers
      3. Cancer research institutes
      4. Others
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Amgen Inc.
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Creative Biolabs
      3. Daiichi Sankyo Company Limited
      4. Genelux Corporation
      5. Oncorus Inc.
      6. Replimune Inc.
      7. Siga Technologies
      8. Sorrento Therapeutics Inc.
      9. TILT Biotherapeutics
      10. Viralytics Ltd.
      11. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate